There are estimated to be more than 18 million people world-wide suffering from
dementia and, on entering the twenty-first century, demographic projections suggest
that there will be a significant growth in elderly populations due to decreasing
infant mortality, improved public health and safety, medical advances, better education
and housing and increased service provision. These population shifts
will predictably lead to a greater demand on medical and welfare services.
Despite the fact that a sizeable proportion of the elderly population will at some
time develop cognitive problems, accurate diagnosis is difficult due to the multiple
pathology involved in these impairments. With the introduction of pharmacological
treatments for cognitive impairments, the emphasis on establishing if people are
suffering from a dementing illness is crucial. Furthermore, patients who are categorized
as ‘subclinical’ cases of cognitive impairment often have an underlying
risk for further progression. Although all clinical definitions of dementia stress
that there must be evidence of intellectual decline, the most common being memory
failure, there is confusion surrounding the nature of cognitive deficits in the three
most commonly applied criteria for dementia – The International Classification
of Diseases (ICD-10), The Diagnostic and Statistical Manual for Mental Disorders
(DSM–IV) and the National Institute of Neurological Disorders and Strokes
(NINDS), Association Internationale pour le Recherche et l’Enseignement en
Neurosciences (AIREN).